Journal Mobile Options
Table of Contents
Vol. 4, No. 2, 2012
Issue release date: May – August
Open Access Gateway
Case Rep Dermatol 2012;4:163–169
(DOI:10.1159/000341563)
Published: August 2012

Multicentric Reticulohistiocytosis Associated with Liver Carcinoma: Report of a Case

Han L. · Huang Q. · Liao K.-H. · Chen L.-J. · Kong W.-Y. · Fu W.-W. · Xu J.
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, PR China

Abstract

We report a unique case of multicentric reticulohistiocytosis (MRH) associated with liver carcinoma. A 61-year-old man presented with a 4-month history of nonpruritic, generalized, ruby-red papules and nodules, accompanied by fever, joint swelling and difficulty in swallowing. Skin histology showed polymorphic histiocyte infiltration with typical ‘ground glass’ cytoplasm. Further immunohistochemical studies characterized the lesions as positive for leukocyte common antigen, HLA-DR and CD68. The patient had a history of hepatitis B, and systemic examination, including carcinoma index and type-B ultrasonic examination, revealed high levels of AFP and a solid tumor, which was considered malignant, localized on the right lobe of the liver. Treatment of the liver carcinoma resulted in a significant improvement of the skin symptoms. This is the first case study to report an association between MRH and liver carcinoma. A review of the English-language literature reveals the close linkage between MRH and malignancy. All patients with MRH should be evaluated and monitored carefully to determine the underlying neoplasm.

 goto top of outline Author Contacts

Lian-Jun Chen
Department of Dermatology, Huashan Hospital

12 Wulumuqi Middle Road
Shanghai 200040 (PR China)
Tel. +86 21 5288 7783, E-Mail lianjunchan@163.com


 goto top of outline Article Information

Published online: August 1, 2012
Number of Print Pages : 7
Number of Figures : 2, Number of Tables : 1,


 goto top of outline Publication Details

Case Reports in Dermatology

Vol. 4, No. 2, Year 2012 (Cover Date: May - August)

Journal Editor: Jemec G.B.E. (Roskilde)
ISSN: 1662-6567 (Print), eISSN: 1662-6567 (Online)

For additional information: http://www.karger.com/CDE


Open Access License / Drug Dosage

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.